Related Experiment Videos
Summary
Differentiated thyroid carcinoma has a good prognosis with surgery and I131 treatment. Undifferentiated thyroid cancers are aggressive and lethal, with limited treatment options and poor survival rates.
Area of Science:
- Endocrinology
- Oncology
Background:
- Thyroid carcinoma is an uncommon malignancy.
- Most thyroid lesions are differentiated types.
Purpose of the Study:
- To review the treatment and outcomes of thyroid carcinoma.
- To differentiate between differentiated and undifferentiated types.
Main Methods:
- Retrospective analysis of thyroid carcinoma cases.
- Surgical management with near-total thyroidectomy.
- Adjuvant radioactive iodine (I131) therapy in select cases.
- Postoperative L-thyroxine hormone replacement therapy.
Main Results:
- Differentiated thyroid carcinomas showed a good prognosis.
- Immediate postoperative mortality was approximately 1%.
- Undifferentiated thyroid carcinomas exhibited rapid growth and high lethality, with poor one-year survival.
Conclusions:
- Near-total thyroidectomy with potential I131 supplementation is the standard for differentiated thyroid cancer.
- L-thyroxine is crucial for postoperative management.
- Effective treatments for undifferentiated thyroid cancer remain elusive.